leflunomide and galactose

leflunomide has been researched along with galactose in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Couch, L; Guo, L; Qing, T; Ren, Z; Shi, L; Tolleson, WH; Xuan, J	1

Other Studies

1 other study(ies) available for leflunomide and galactose

Article	Year
Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology, 2018, 03-01, Volume: 396-397 Topics: Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Bongkrekic Acid; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Galactose; Glucose; Hep G2 Cells; Humans; Isoxazoles; L-Lactate Dehydrogenase; Leflunomide; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Phosphorylation	2018

Article

Year

Mitochondrial dysfunction induced by leflunomide and its active metabolite.

Toxicology, 2018, 03-01, Volume: 396-397

Topics: Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Bongkrekic Acid; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Stress; Galactose; Glucose; Hep G2 Cells; Humans; Isoxazoles; L-Lactate Dehydrogenase; Leflunomide; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Phosphorylation

2018